CytoAgents, Inc

CytoAgents, Inc

Biotechnology Research Alloy 26, 100 S. Commons 10 employees
Employees
10
Contacts
3
Emails
3
Phones
3

CytoAgents, Inc Overview

Headquarters
Alloy 26, 100 S. Commons
Website
cytoagents.com
Industry
Biotechnology Research
Employees
10
Founded
2018
Funding
2.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About CytoAgents, Inc

CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.

CytoAgents, Inc Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
3
75.0% coverage

CytoAgents, Inc Org Chart

Sample employees and titles
Name Title Contact
Sreekar Gadde Early-stage, High-growth
Email Phone
Roy Prieb
Email Phone
Anthony Mccarley Ceo│business Coach│executive
View
Carl Nicolia President at Psnergy Llc
Email Phone

Employees by Management Level

Executive 2 profiles
Individual contributor 1 profile

Compare Similar Companies to CytoAgents, Inc